MARKET

ELDN

ELDN

Eledon Pharmaceuticals Inc
NASDAQ
3.850
-0.020
-0.52%
Opening 11:47 05/29 EDT
OPEN
3.880
PREV CLOSE
3.870
HIGH
3.895
LOW
3.775
VOLUME
269.36K
TURNOVER
--
52 WEEK HIGH
4.600
52 WEEK LOW
1.350
MARKET CAP
297.17M
P/E (TTM)
-4.6514
1D
5D
1M
3M
1Y
5Y
1D
NewcelX submits NCEL-101 pre-investigational new drug briefing package to FDA
TipRanks · 2d ago
EXCLUSIVE: NewcelX Advances Diabetes Therapy Toward Human Trials With FDA Pre-IND Submission
Benzinga · 2d ago
Weekly Report: what happened at ELDN last week (0518-0522)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Whitehawk Therapeutics (WHWK) and Eledon Pharmaceuticals (ELDN)
TipRanks · 05/22 14:00
Eledon Pharma To Highlight New Clinical Data From Tegoprubart Program In Patients Undergoing Kidney Transplantation In Oral And Poster Presentation At ATC 2026
Benzinga · 05/20 20:16
Eledon presents new long-term Phase 2 BESTOW kidney transplant data for tegoprubart at ATC
PUBT · 05/20 20:06
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 05/18 13:30
Weekly Report: what happened at ELDN last week (0511-0515)?
Weekly Report · 05/18 10:34
More
About ELDN
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular pathway. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. Tegoprubart is engineered to potentially both improve safety and provides pharmacokinetic, pharmacodynamic, and dosing advantages. CD40L is primarily expressed on activated CD4+ T cells, platelets, and endothelial cells while the CD40 receptor is constitutively expressed on antigen-presenting cells, such as macrophages and dendritic cells, as well as B cells.

Webull offers Eledon Pharmaceuticals Inc stock information, including NASDAQ: ELDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELDN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELDN stock methods without spending real money on the virtual paper trading platform.